An adolescent case of sulfhemoglobinemia associated with high-dose metoclopramide and N-acetylcysteine

被引:15
|
作者
Langford, JS [1 ]
Sheikh, S [1 ]
机构
[1] Univ Louisville, Dept Emergency Med, Louisville, KY 40292 USA
关键词
D O I
10.1016/S0196-0644(99)80058-4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
We describe the case of an adolescent girl who received high-dose metoclopramide in combination with oral N-acetylcysteine therapy for acute acetaminophen toxicity. Whole blood-sample analysis for abnormal hemoglobin pigments established the diagnosis of sulfhemoglobinemia. Metoclopramide has been shown to cause sulfhemoglobinemia, particularly when used in repeated high doses. Although N-acetylcysteine alone has not been associated as the cause, we suggest that sulfhemoglobinemia is a potential complication in patients treated with metoclopramide for the nausea that often accompanies oral N-acetylcysteine therapy for acetaminophen toxicity. Cyanosis without respiratory distress should suggest this diagnosis.
引用
收藏
页码:538 / 541
页数:4
相关论文
共 50 条
  • [1] High-dose N-acetylcysteine in an immunocompromised patient with COVID-19
    Lai, K. Y.
    Au, S. Y.
    Sin, K. C.
    Yung, S. K.
    Leung, Anne K. H.
    HONG KONG MEDICAL JOURNAL, 2024, 30 (01) : 69 - 71
  • [2] Treatment of advanced malignancies with high-dose acetaminophen and N-acetylcysteine rescue
    Kobrinsky, NL
    Hartfield, D
    Horner, H
    Maksymiuk, A
    Minuk, GY
    White, DF
    Feldstein, TJ
    CANCER INVESTIGATION, 1996, 14 (03) : 202 - 210
  • [3] High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy
    Marenzi, G.
    Trivedi, H.
    Daram, S.
    Szabo, A.
    Bartorelli, A. L.
    EUROPEAN HEART JOURNAL, 2009, 30 : 298 - 299
  • [4] High-dose N-acetylcysteine for the Prevention of Contrast-induced Nephropathy
    Trivedi, Hariprasad
    Daram, Sumanth
    Szabo, Aniko
    Bartorelli, Antonio L.
    Marenzi, Giancarlo
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (09): : 874.e9 - 874.e15
  • [5] Efficacy of high-dose N-acetylcysteine in acute GVHD prophylaxis.
    Tagliaferri, E
    Soligo, D
    Onida, F
    Della Volpe, A
    Bertolli, V
    Deliliers, GL
    BONE MARROW TRANSPLANTATION, 1998, 21 : S120 - S120
  • [6] Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy
    Reena V. Kartha
    Jie Zhou
    Lisa Basso
    Henning Schröder
    Paul J. Orchard
    James Cloyd
    CNS Drugs, 2015, 29 : 1041 - 1047
  • [7] High-dose N-acetylcysteine in the prevention of COPD exacerbations: Results of the PANTHEON study
    Zheng, Jin-Ping
    Wen, Fu Qiang
    Bai, Chun-Xue
    Wan, Huan-Ying
    Kang, Jian
    Chen, Ping
    Yao, Wan-Zhen
    Ma, Li-Jun
    Li, Xia
    Gao, Yi
    Zhong, Nan-Shan
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [8] Benefits of High-Dose N-Acetylcysteine to Exacerbation-Prone Patients With COPD
    Hoi Nam Tse
    Raiteri, Luca
    Wong, King Ying
    Ng, Lai Yun
    Yee, Kwok Sang
    Tseng, Cee Zhung Steven
    CHEST, 2014, 146 (03) : 611 - 623
  • [9] High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease
    Zuin, R
    Palamidese, A
    Negrin, R
    Catozzo, L
    Scarda, A
    Balbinot, M
    CLINICAL DRUG INVESTIGATION, 2005, 25 (06) : 401 - 408
  • [10] High-Dose N-Acetylcysteine in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease
    R. Zuin
    A. Palamidese
    R. Negrin
    L. Catozzo
    A. Scarda
    M. Balbinot
    Clinical Drug Investigation, 2005, 25 : 401 - 408